Bu Y. et al. identified that miR-211 directly targets to Bmal1 and Clock in Burkitt’s lymphoma, thereby suppressing both circadian oscillation and ongoing protein synthesis to facilitate tumor progression (Bu et al., 2018). This evidence concerns the gene CLOCK and Burkitt lymphoma.